News

The findings highlight new data on AXL expression in inflammatory diseases.

After 4 weeks of daily use, 92% of participants showed an improvement in skin hydration.

The procedure was both effective and safe in a small cohort of patients with refractory hidradenitis suppurativa of the axilla.

As Hair Loss Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top hair loss headlines and news from August.

Learn more about the in-depth topics covered in the August 2023 issue of Dermatology Times.

Research continues to show that food plays a large role in skin diseases.

From its clinical study, 97% of patients saw improvement in acne scars after 3 treatment sessions.

Image-Guided Superficial Radiation Therapy kills cancer cells without surgery.

Allergan Aesthetics has shared details of a recently-published analysis involving patient-reported satisfaction, including natural-looking outcomes, with OnabotulinumtoxinA (Botox) treatment.

In this week’s Pointers With Portela, the 208SkinDoc asks consumers skin health and skin care trivia questions about adequate sleep, SPF reapplication, melasma, and more.

As Psoriasis Awareness Month 2023 comes to a close, Dermatology Times is reviewing the top psoriasis headlines and news from August.

Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.

The post hoc analysis published in JAMA Dermatology studied the safety and efficacy of tralokinumab in adults aged 65 and older.

The American Acne and Rosacea Society selected Bunick’s research on tetracycline-class compounds for the award.

The treated areas remained clear up to 18 months after treatment with follicular unit excision.

Investigators recommended further studies exploring the confounding variables that may contribute to higher rates of skin cancers in this patient population.

There are simple tools that can help us achieve the best employment contract.

Click here to answer this week's melasma poll.

Patients with psoriasis treated with IL-23i and IL-17i had a decreased risk of developing pneumonia, otitis media, and upper respiratory tract infections.

Scientists say the new findings could lead to new drugs for vitiligo and other pigmentation diseases.

Longevity Playbook helps individuals understand how their lifestyle choices affect signs of aging.

This Hair Loss Awareness Month, let us know your experiences. Click here to answer this week's poll.

All participants showed fewer fine lines by the end of the 12-week study.

Keep up with the latest headlines in dermatology from the past week, including growing concerns of a dermatologist shortage in Ontario, LEO Pharma's acquisition of Timber Pharmaceuticals, and more. This week, we have also included a patient-forward rundown of top headlines to share with your patients.

ICYMI, this week we had stories about clascoterone cream 1% for acne vulgaris management, CRH-R1 increases in psoriasis and actinic keratosis mast cells, cannabinoid use in dermatology, and more.

Lauren Miller, MPAS, and T.J. Chao, MPAS, emphasized that clinicians need to be an advocate for patients and take that extra step to educate.

Attendees learned about a variety of professions in healthcare and how to prepare for them.

Providers have been eagerly awaiting the approval of VP-102, as molluscum contagiosum accounts for approximately 1% of all diagnosed skin conditions.

The OCCUPES study examined the patient burden associated with foot dermatoses and work-related skin diseases and the implications of a prevention program.

Researchers noted a lack of significant differences in access to biologics among different populations.